All articles tagged with #cardiovascular disease
Researchers show gut bacteria transform nitrate and plant-based iron from vegetables into dinitrosyl iron complexes (DNICs) that travel to the liver and kidneys; in animal models, higher DNIC levels were linked to lower blood pressure, better blood sugar control, improved vascular function, and reduced liver fat, offering a possible mechanism for vegetables' protective effects—though human studies are needed.
A European Journal of Clinical Nutrition study of over 31,000 adults aged 40+ found that starting the first meal after noon is linked to higher death risk: 29% more all-cause mortality for noon-or-later breakfasts versus 7–8 a.m.; 8–10 a.m. (+10%) and 10 a.m.–noon (+19%) also show increased risk. Cardiovascular death was 46% higher for noon eaters versus early breakfast eaters, and those aged 50+ who ate later had about 2.5 fewer years of life on average. The findings show association, not causation, but suggest meal timing may influence longevity beyond diet itself.
A diagonal earlobe crease, known as Frank’s sign, may be linked to higher cardiovascular risk, but it is not a diagnosis. Doctors say it should be seen as a possible clue alongside standard risk assessments and tests. If you notice a crease, discuss it with your physician, while continuing heart‑healthy habits (managing blood pressure, cholesterol, blood sugar, weight, activity, and smoking) and pursuing appropriate evaluations based on your overall risk profile.
A new review links women's reproductive health history to later heart disease risk, highlighting pregnancy complications (preeclampsia, gestational hypertension, premature birth, gestational diabetes), PCOS/PMOS, endometriosis, migraine with aura, and menopause timing as potential risk markers; three French programs show gynecological clinics can help identify undiagnosed cardiovascular risk, suggesting perimenopause and menopause as key windows for heart health screening—though these are risk factors, not guarantees.
A meta-analysis of 17 studies (226,889 people) published in the European Journal of Preventive Cardiology finds you don't need 10,000 steps to gain health benefits: about 3,967+ steps per day lowers all-cause mortality, 2,337+ steps per day lowers cardiovascular mortality, and every 1,000-step increase lowers all-cause risk by 15% while every 500-step increase lowers cardiovascular risk by 7%. Benefits scale with activity, peaking around 6,000–10,000 steps per day, with 20,000+ steps linked to the lowest risk. The study also notes that the American Heart Association's recommendation of 150 minutes of moderate activity can be met through everyday activities like walking, gardening, or walking a dog, not just formal exercise.
A meta-analysis of data from over 480,000 people across nine studies with a median follow-up of 14 years found that stair climbing is associated with a 39% lower risk of cardiovascular death and a 24% lower risk of death from any cause. Some evidence suggests climbing about six flights per day may offer the greatest benefit, though the researchers caution this is observational and does not prove causation. Stair climbing is a simple, cost-free way to boost heart health and can be practical for people with limited time for traditional exercise, but may not suit everyone due to mobility issues or joint conditions.
A JAMA analysis of the 2026 ACC/AHA cholesterol guidelines shows 21.5 million more U.S. adults now qualify for statins, bringing the total to about 87.5 million. The expansion focuses on long-term lifetime risk rather than just 10-year risk, with older adults and people with risk factors more likely to qualify. Whether to start a statin should be individualized, possibly aided by tests like coronary calcium scoring, alongside lifestyle changes; statins are generally safe with mostly minor side effects.
A French randomized trial in healthy adults around age 80 found that stopping statins at age 75 did not worsen three-year outcomes compared with continuing them; LDL rose after stopping, but death rates and major cardiovascular events were similar and quality of life remained unchanged. The findings may apply only to low-risk, healthy elderly populations and should not change practice broadly; decisions should be individualized and confirmed with longer follow-up and diverse populations.
Therapeutic apheresis, a blood-filtering therapy for lowering lipoproteins in severe cardiovascular disease, was found in small studies to also reduce circulating PFAS levels—up to 25% after one session in one protocol and 43.5–75.8% across five PFAS in another—while microplastic results were mixed and subject to measurement challenges. Researchers caution that these are exploratory, with small sample sizes and methodological differences; there is no proven reduction in total body PFAS or microplastics burden, and more controlled trials are needed before considering apheresis as a pollutant detox.
A new study using NHANES data estimates that the updated 2025 hypertension guidelines would make about 81 million US adults eligible for blood pressure medications; roughly 23 million would become newly eligible and about 9.7 million are currently untreated. Implementing the guidelines could reduce all-cause mortality by about 23% and cardiovascular deaths by about 50% over the next 10 years, with the biggest benefits for those with diabetes. Experts stress that meds work best when paired with lifestyle changes and efforts to improve adherence.
A large observational study of about 150,000 health professionals over 30 years finds that engaging in about 90–120 minutes of strength training weekly is linked to roughly a 13% lower risk of all-cause mortality, with larger reductions for cardiovascular (19%) and neurological (27%) deaths; when combined with at least 150 minutes of regular aerobic activity, overall mortality drops by about 45%. Benefits plateau after about two hours per week; the muscle-driven effects likely come from improved glucose handling and myokine signaling, though causality can’t be proven from observational data.
CKM syndrome ties obesity, metabolic disorders, kidney disease, and cardiovascular disease into a five-stage continuum from optimal health (Stage 0) to established cardiovascular disease (Stage 4); early detection through broad risk screening and management with lifestyle changes (weight loss, DASH/Mediterranean diet, exercise, sleep, stress reduction) and medications (SGLT2 inhibitors, GLP-1 agonists) can slow progression and protect heart and kidney function.
A UK Biobank study of 340k adults over ~13 years finds heavy drinking raises death risk for all beverages, but at low to moderate levels wine is linked to a 21% lower risk of cardiovascular death, while beer, cider, and spirits are linked to about 9% higher cardiovascular death risk; authors caution observational design and lifestyle confounds, suggesting beverage type matters alongside amount.
New research suggests avoiding three midlife vascular risk factors—high blood pressure, diabetes, and smoking—could extend dementia-free years by about 13, highlighting the brain-heart health link; the study is observational and cannot prove causation.
A cardiologist warns energy drinks, which combine caffeine with stimulants like taurine and guarana, can provoke dangerous heart rhythms and even cardiac arrest in people with heart disease; he urges heart patients to avoid them and suggests black coffee as a safer option, noting that up to 400 mg of caffeine daily is safe for most adults while energy drinks can be addictive and harm cardiovascular health.